BIMI International Medica... (BIMI)
OTC: BIMI
· Real-Time Price · USD
0.00
-0.00 (-100.00%)
At close: Mar 14, 2025, 11:02 AM
BIMI International Medical Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 994.13K | 1.93M | 1.73M | 2.34M | 1.05M | 5.03M | 1.61M | 4.8M | 209.8K | 626.55K | 2.83M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | 1.8M | n/a | -197.17K | -1.01M | -207.55K | -363.68K | -1.23M | -1.23M |
Other Long-Term Assets | 3.38M | 3.44M | 3.7M | 3.76M | 180K | 197.17K | 1.01M | 207.55K | 363.68K | 1.23M | 1.23M |
Receivables | 5.02M | 7.3M | 4.84M | 4.18M | 9.21M | 8.72M | 10.35M | 5.87M | 12.81M | 9.55M | 7.35M |
Inventory | 7.09M | 7.18M | 8.47M | 7.65M | 1.23M | 3.03M | 2.17M | 2.64M | 2.12M | 5.12M | 3.57M |
Other Current Assets | 2.15M | 2.56M | 2.24M | 2.1M | 794.44K | 794.07K | 1.01M | 356.95K | 368.32K | 1.28M | 1.28M |
Total Current Assets | 24.37M | 26M | 24.98M | 23.24M | 17.38M | 24.18M | 22.05M | 21.16M | 26.3M | 25.63M | 21.7M |
Property-Plant & Equipment | 4.58M | 4.53M | 4.82M | 4.65M | 6.86M | 7.45M | 8.06M | 8.37M | 6.11M | 6.34M | 3.34M |
Goodwill & Intangibles | 2.53M | 2.51M | 2.58M | 2.08M | 8.39M | 8.39M | 8.39M | 8.39M | 30.46M | 30.46M | 24.53M |
Total Long-Term Assets | 10.67M | 10.66M | 11.3M | 12.48M | 15.62M | 16.04M | 16.66M | 16.97M | 36.78M | 36.99M | 28.05M |
Total Assets | 35.04M | 36.66M | 36.27M | 35.71M | 33M | 40.22M | 38.71M | 38.13M | 63.08M | 62.61M | 49.75M |
Account Payables | 10.44M | 9.61M | 10.09M | 10.79M | 4.23M | 5.85M | 6.63M | 7.34M | 13.47M | 10.86M | 10.18M |
Deferred Revenue | 761.76K | 524.79K | 1.15M | 923.13K | 1.52M | 2.32M | 2.45M | 1.94M | 392.49K | 3.42M | 529.28K |
Short-Term Debt | 1.27M | 1.24M | 1.77M | 1.35M | 2.22M | 2.54M | 2.72M | 6.35M | 6.59M | 1.67M | 6.99M |
Other Current Liabilities | 6.96M | 3.13M | 3.29M | 3.92M | 5.67M | 5.61M | 5.03M | 5.04M | n/a | 5.71M | n/a |
Total Current Liabilities | 20.16M | 19.39M | 22.61M | 25.36M | 18.9M | 21.51M | 20.69M | 22.09M | 24.19M | 27.66M | 23.45M |
Long-Term Debt | 24.37K | 126.28K | 160.08K | 2.89M | 3.89M | 4.31M | 4.62M | 1.94M | 794.54K | 4.32M | 1.82M |
Other Long-Term Liabilities | 2.27M | 2.21M | 2.3M | -329.38K | -3.42M | -3.84M | -4.09M | 1.36M | n/a | -3.39M | -1.4M |
Total Long-Term Liabilities | 4.74M | 4.76M | 5.05M | 5.13M | 3.89M | 4.31M | 4.62M | 4.7M | 4.1M | 4.32M | 1.82M |
Total Liabilities | 24.9M | 24.15M | 27.65M | 30.5M | 22.79M | 25.82M | 25.32M | 26.79M | 28.29M | 31.97M | 25.27M |
Total Debt | 4.47M | 4.43M | 5.18M | 5.46M | 12.62M | 13.36M | 13.29M | 13.03M | 11.39M | 12.46M | 9.16M |
Common Stock | 6.67K | 6.26K | 4.04K | 3.77K | 38.44K | 22.86K | 10.36K | 8.5K | 32.42K | 24.79K | 20.13K |
Retained Earnings | -71.43M | -68.3M | -71.03M | -70.14M | -58.5M | -54.6M | -50.64M | -47.9M | -18.23M | -16.52M | -16.25M |
Comprehensive Income | -1.13M | 1.76M | 1.2M | 2.29M | 2.5M | 2.9M | 3.32M | 3.87M | 3.14M | 3.27M | 3.12M |
Shareholders Equity | 8.71M | 10.89M | 7.61M | 4.05M | 9.8M | 14.16M | 13.25M | 11.19M | 34.53M | 30.39M | 24.25M |
Total Investments | n/a | n/a | n/a | 1.8M | n/a | -197.17K | -1.01M | -207.55K | -363.68K | -1.23M | -1.23M |